Saturday 17 October 2026
Export MBAI’s income statement to Excel — free account
MBody AI Ltd.
MBAI Healthcare Diagnostics & Research
Operating cash flow growth for three consecutive years.
2.75
0.35
−11.29%
Follow MBAI
MBody AI Ltd. (MBAI) P/E ratio
MBody AI Ltd. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 0.0× (October 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BNR Burning Rock Biotech Limited Sponsored ADR compare | n/m |
| MDXHF MedX Health Corp. compare | n/m |
| MBAI MBody AI Ltd. | n/m |
| PMD Psychemedics Corporation compare | n/m |
| QUCY Quantum Cyber N.V compare | n/m |
| MDXH MDxHealth SA compare | n/m |
| XGN Exagen Inc. compare | n/m |
| PRPO Precipio, Inc. compare | n/m |
| IMDX Insight Molecular Diagnostics Inc. compare | n/m |
| Diagnostics & Research industry median | 35.6× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)